Hepatitis B blood test to predict treatment outcomes
Part of Cancer, Infections clinical trials.
This study looks at a blood marker called HBV pgRNA to see if it can predict long-term outcomes for people with hepatitis B who are on antiviral therapy. It might help doctors better understand how well treatment is working.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have chronic hepatitis B, meaning you've had a positive hepatitis B test for at least 6 months.
- You are between 18 and 80 years old.
- You are about to start or have already started a standard hepatitis B treatment, such as peginterferon, tenofovir, entecavir, or a combination.
- You do not have any cancer other than liver cancer.
- You are willing to sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study compares two ways of giving treatment for chronic hepatitis B: continuous antiviral therapy versus pulsed treatment. It may help find a schedule that works well and is tolerable for people with hepatitis B.
This study looks at how to best use existing hepatitis B “nucleotide-analog” tablets in everyday care. It may help tailor when to start, and whether to continue or adjust treatment, based on your test results.
This study looks at a new way to detect the hepatitis B virus in the blood, even after standard tests say it's gone. It may help people who have stopped treatment and want to see if the virus comes back.
This study looks at long-term outcomes in people with chronic hepatitis B who take antiviral medicines or receive interferon. It may help doctors understand which treatments work best over time and who is most likely to benefit.
This study looks at the genes of people with chronic hepatitis B (HBV) to find why some people's immune cells (B cells and NK cells) stop working properly. The goal is to discover new ways to treat the disease.
This study builds a group of people to measure small hepatitis B “viral RNA” signals in the blood. The goal is to see if these measurements could help researchers find a functional cure and better understand who may respond over time.
Hear when a new HBV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.